GMS Holdings

GMS Holdings is a private investment institution that manages a diversified portfolio of assets globally, with a primary focus on the life sciences and healthcare sectors. Headquartered in Amman, Jordan, the firm is the majority owner of MS Pharma, a leading pharmaceutical group with a strong manufacturing and commercial presence across the Middle East, North Africa, and Turkey. The company's investment strategy emphasizes long-term value creation through the development of high-quality generic pharmaceuticals, biosimilars, and value-added medicines. In addition to its core pharmaceutical holdings, GMS Holdings has expanded into biotechnology through strategic stakes in companies like GenePharma and Stelis Biopharma. The group operates several state-of-the-art R&D and GMP-certified manufacturing facilities, enabling the production of diverse dosage forms including oral solids, injectables, and biologics. By bridging the gap between global innovation and regional market needs, GMS Holdings plays a critical role in improving healthcare access in emerging markets.